Serial Number
98466467
Owner
Shenzhen Jingtai Technology Co., Ltd.Attorney
Joseph V. Myers IIIFirst Use Date
Aug 10, 2022
Filing Date
Mar 25, 2024
XTALPI X Trademark
Serial Number: 98466467 • Registration: 8138338
Trademark Classes
Class 7 - Machinery
Machines and machine tools; motors and engines; machine coupling and transmission components
Class 9 - Computers & Electronics
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Floor 3, 289 Digitland, No.2 Hongliu Road, Fubao Community, Fubao Street, Futian District,
Shenzhen, Guangdong, 518017 , CN
Entity Type: 99
Legal Representation
Correspondence Address
Joseph V. Myers III Seyfarth Shaw LLP
1075 Peachtree St. NE
Suite 2500
Atlanta, GA 30309
United States
Trademark Details
Filing Date
March 25, 2024
Registration Date
February 10, 2026
First Use Anywhere
August 10, 2022
First Use in Commerce
April 1, 2024
Published for Opposition
November 5, 2024
Goods & Services
machine used for process filtration in the pharmaceutical industry; blending machines for chemical processing; dissolving machines for chemical processing; filtering machines for chemical processing; industrial mixer for mixing liquids in the pharmaceutical and chemical industries; capping machines; industrial robots
electro-dynamic apparatus for the remote control of signals; surveying apparatus; dosage dispensers for measuring and dispensing portions of fluids, powders, solid granules, not for medical use; laboratory robots; precision balances
technical research in the field of pharmaceutical studies; research and development of new products for others; scientific laboratory services; research laboratory analysis services in the field of chemistry; chemical research; biological research; pharmaceutical research services; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical research and development; research and development services in the field of antibodies; testing of pharmaceuticals; computer software design; software as a service (SAAS) services in the nature of hosting cloud-based software of others; design and development of operating software for accessing and using a cloud computing network; research in the field of artificial intelligence; pharmaceutical drug development services; computer services, namely, integration of private and public cloud computing environments